Eyes Wide Open - Steroids and Vision Risks

Can the medication that keeps someone alive also put their eyesight at risk?

In this episode, Chloe and Alex take a careful, grounded deep dive into the My Adrenal Life article “Vision Changes, Glaucoma, and Cataracts in Long-Term Steroid Use.” Together, they explore one of the most emotionally loaded topics in the adrenal insufficiency community: the fear that long-term steroid use could affect vision.

This conversation approaches that fear with clarity rather than panic. For people living with primary adrenal insufficiency (Addison’s disease), secondary adrenal insufficiency, tertiary adrenal insufficiency, or steroid-induced adrenal insufficiency, steroids are not optional. They are lifesaving. But that does not mean questions about long-term eye health should be dismissed.

Chloe and Alex explain the two major eye concerns most commonly linked to steroid exposure: cataracts and steroid-related eye pressure rise that can contribute to glaucoma.

The episode breaks down how cataracts form when the eye’s natural lens becomes cloudy, and why steroid use is especially associated with a type called posterior subcapsular cataracts. These can cause blurry vision, glare, halos around lights, trouble reading, and increasing difficulty driving at night. The conversation also offers an important reminder: cataracts are common with aging too, and while steroids can increase risk for some people, they do not make cataracts inevitable.

Chloe and Alex then turn to ocular hypertension and glaucoma, which many patients fear even more because glaucoma can damage the optic nerve over time. One of the most important points in the episode is that rising eye pressure often causes no early symptoms at all. That is why monitoring matters so much. The goal is not to create fear, but to catch problems early if they develop.

Another major theme is the difference between replacement-dose steroids and high-dose anti-inflammatory steroid therapy. These are not the same thing, and confusing them can create unnecessary panic. The discussion explains why people with adrenal insufficiency who take physiologic replacement doses are not in the same risk category as someone taking repeated high-dose steroid bursts for autoimmune disease or severe inflammation. At the same time, it reinforces that replacement dosing does not automatically mean zero risk, especially over many years or when other steroid forms are added in.

The episode also covers why route matters. Steroid eye drops, oral steroids, inhalers, nasal sprays, creams near the eyes, injections, and other forms may all contribute differently depending on dose, duration, and individual sensitivity.

Chloe and Alex also touch on another less commonly discussed issue: central serous chorioretinopathy (CSC), a steroid-linked condition involving fluid under the retina that can cause sudden blurry or distorted central vision.

Most importantly, this episode reframes monitoring as a form of protection, not panic. A “steroid-aware” eye exam may include vision testing, eye pressure checks, a dilated exam, optic nerve evaluation, and sometimes imaging or visual field testing. These tools can catch changes early and replace vague fear with real information.

If you have ever worried that steroid treatment could affect your sight, this conversation offers a calmer, clearer way to understand the risks without spiraling into worst-case thinking.

Visit us at www.MyAdrenalLife.com and our Facebook Group